SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022445
Filing Date
2017-11-08
Accepted
2017-11-07 21:44:28
Documents
53
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-10q_20170930.htm 10-Q 1472607
2 EX-10.1 nktr-ex101_179.htm EX-10.1 497835
3 EX-10.2 nktr-ex102_237.htm EX-10.2 763671
4 EX-31.1 nktr-ex311_7.htm EX-31.1 16070
5 EX-31.2 nktr-ex312_8.htm EX-31.2 16082
6 EX-32.1 nktr-ex321_6.htm EX-32.1 7779
7 GRAPHIC g20171108022352500620.jpg GRAPHIC 8013
8 GRAPHIC g20171108022405284821.jpg GRAPHIC 40735
9 GRAPHIC g20171108022408943821.jpg GRAPHIC 49503
  Complete submission text file 0001564590-17-022445.txt   6290301

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT nktr-20170930.xml EX-101.INS 805435
11 XBRL TAXONOMY EXTENSION SCHEMA nktr-20170930.xsd EX-101.SCH 51893
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20170930_cal.xml EX-101.CAL 48492
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20170930_def.xml EX-101.DEF 131327
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20170930_lab.xml EX-101.LAB 353494
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20170930_pre.xml EX-101.PRE 241913
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 171184909
SIC: 2834 Pharmaceutical Preparations